Exo set to accelerate its game-changing ultrasound technology development
Exo Imaging, a leading innovator in ultrasound medical imaging technology, today announced a strategic collaboration with Samsung Medison to co-develop advanced ultrasound solutions. The partnership includes a strategic equity investment by Samsung, aimed at accelerating the development of next-generation ultrasound platforms. Exo is also delighted to welcome Omar Ishrak to its Board as Chair of Strategy.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250528970289/en/
Exo® Announces Samsung Medison Strategic Collaboration and Welcomes Omar Ishrak to its Board
Dr. Kyu Tae Yoo, CEO of Samsung Medison, welcomed the partnership with Exo. “Our collaboration with Exo marks a significant step toward advancing transformation in ultrasound imaging. We are committed to delivering innovation that improves diagnostic capabilities and enhances the clinical experience for patients and practitioners alike.”
Omar Ishrak— Chairman of Qubit Health Capital, former Chairman and CEO of Medtronic, and prior CEO of GE Healthcare Systems said, “Exo’s technology has the potential to significantly improve diagnostic precision and accessibility. I look forward to helping guide the clinical strategy and long-term vision behind this important collaboration.”
Exo is pioneering a new era in ultrasound by combining advanced silicon-based architectures with embedded ultrasound technology. The company is focused on creating imaging systems that are compact, high-performance, with potential applications across a variety of care settings. This collaboration is expected to lay the foundation for future innovation in real-time imaging.
The partnership reflects a shared vision between Exo and Samsung Medison to drive global advancement in ultrasound through large-scale innovation and strategic co-development.
About Exo Imaging
Exo is redefining medical imaging with its advanced ultrasound platform, combining novel silicon-based hardware, tightly coupled AI, and easy-to-use collaboration software. Its handheld and soon-to-be OEM-integrated systems deliver high-performance imaging and real-time clinical intelligence, driving better, more accessible diagnostics and outcomes across diverse care settings.
Learn more at www.exo.inc.
About Samsung Medison
Samsung Medison is the largest manufacturer of ultrasound diagnostic systems in Korea and handles domestic sales and service of Samsung Electronics’ digital X-ray systems, and portable CTs, founded in 1985. With a mission to add the values of health and happiness to human life, the company has integrated information technology, video signal processing, semiconductor, and communication technologies in various medical fields to develop supplementary diagnostic AI tools for quick and accurate diagnosis. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices. Follow us on LinkedIn for the latest news or visit our website https://www.samsunghealthcare.com/en for more information.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250528970289/en/
"Our collaboration with Exo marks a significant step toward advancing transformation in ultrasound imaging." - Dr. Kyu Tae Yoo, CEO of Samsung Medison
